The diagnostic use of procalcitonin for bacterial infections remains a matter of debate. Most
studies have used ambiguous outcome measures such as sepsis instead of infection. We …

Objective: The use of procalcitonin (ProCT) as a marker of several clinical conditions, in
particular, systemic inflammation, infection, and sepsis, will be clarified, and its current …

Patients with infective endocarditis (IE) form a heterogeneous group, ranging from those
who are successfully treated with no adverse events, to those with severe complications and …

Background This study aimed to evaluate the accuracy of procalcitonin (PCT) serum
concentrations to diagnose Gram-negative bacteremia and the association of PCT serum …

Background In the ICU, bacteremia is a life-threatening infection whose prognosis is highly
dependent on early recognition and treatment with appropriate antibiotics. Procalcitonin …

Recent data and cumulative analyses indicate that biomarkers of sepsis improve diagnosis
of sepsis. However, only a few markers have impact on therapy and fulfill the clinical …

Background Procalcitonin is useful for the diagnosis of sepsis but its prognostic value
regarding mortality is unclear. This prospective observational study was designed to study …

Background Procalcitonin (PCT) is widely used in critically ill patients to diagnose clinically
significant infection and sepsis. Aim of this study was to evaluate the prognostic value of …

Background—Variability in the clinical presentation of infective endocarditis (IE) makes the
diagnosis a clinical challenge. We hypothesized that serum procalcitonin, a marker of …

Background The early identification of patients at risk of complications of infective
endocarditis (IE) using parameters obtained as part of routine practice is essential for …